Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satish Garg

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Diabetes Care|November 30, 2006
Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensorSatish Garg, Lois Jovanovic
Current Opinion in Endocrinology, Diabetes, and Obesity|February 6, 2019
Technological advances shaping diabetes careHalis Kaan Akturk, Satish Garg
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care settingStephen N Davis, Wenhui Wei, Satish Garg
Expert Review of Medical Devices|March 12, 2008
Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetesSamita Garg, William Charles Kelly, Satish Garg
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2010
Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitusSatish Garg, Francisco Javier Ampudia-Blasco, Martin Pfohl
Diabetes Technology & Therapeutics|October 26, 2010
Clinical experience with insulin glargine in type 1 diabetesSatish Garg, Emily Moser, Marie-Paule Dain, et al.
Psychosomatic Medicine|January 31, 2002
Self-efficacy impacts self-care and HbA1c in young adults with Type I diabetesCatharine H Johnston-Brooks, Megan A Lewis, Satish Garg
The Journal of Clinical Endocrinology and Metabolism|November 27, 2019
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN TrialsCyrus DeSouza, Bertrand Cariou, Satish Garg, et al.
Diabetes, Obesity & Metabolism|December 3, 2019
Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetesHalis Kaan Akturk, Dominique Giordano, Anagha Champakanath, et al.
Diabetes Care|December 24, 2005
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trialSatish Garg, Howard Zisser, Sherwyn Schwartz, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Diabetes Care|November 30, 2006
Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensorSatish Garg, Lois Jovanovic
Current Opinion in Endocrinology, Diabetes, and Obesity|February 6, 2019
Technological advances shaping diabetes careHalis Kaan Akturk, Satish Garg
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care settingStephen N Davis, Wenhui Wei, Satish Garg
Expert Review of Medical Devices|March 12, 2008
Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetesSamita Garg, William Charles Kelly, Satish Garg
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2010
Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitusSatish Garg, Francisco Javier Ampudia-Blasco, Martin Pfohl
Diabetes Technology & Therapeutics|October 26, 2010
Clinical experience with insulin glargine in type 1 diabetesSatish Garg, Emily Moser, Marie-Paule Dain, et al.
Psychosomatic Medicine|January 31, 2002
Self-efficacy impacts self-care and HbA1c in young adults with Type I diabetesCatharine H Johnston-Brooks, Megan A Lewis, Satish Garg
The Journal of Clinical Endocrinology and Metabolism|November 27, 2019
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN TrialsCyrus DeSouza, Bertrand Cariou, Satish Garg, et al.
Diabetes, Obesity & Metabolism|December 3, 2019
Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetesHalis Kaan Akturk, Dominique Giordano, Anagha Champakanath, et al.
Diabetes Care|December 24, 2005
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trialSatish Garg, Howard Zisser, Sherwyn Schwartz, et al.
Pageof 4